NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/12/2024
Voltar para busca
Dado oficial do USPTO
EXACTIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EXACTIS
ST13
US500000086534923Classe
35, 36, 42, 44
Pedido
86534923
Registro
5505700
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
10/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 44
Data de depósito
13/02/2015
Data de registro
03/07/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/12/2024
Última transação
10/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Montréal, Québec, CA
Examinador
LAW, CHRISTOPHER
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
I. E. (pessoa física)
I. E. (pessoa física)
Representantes
Christie Baty Hudgins Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting collaboration and the exchange of information and resources within the scientificresearchmedicalclinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatment
Classe 36
Financial sponsorship of clinical and translational trials in the field of cancer treatment
Classe 42
Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing research information in the nature of medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of cancer treatment for others; Providing clinical trial information in the nature of research data pertaining to cancer
Classe 44
Providing medical information with profiles of cancer patients' tumours and the associated clinical and molecular datacancer drugsbiomarkersbiological and tissue samplesresults of clinical studiesvia an on-line searchable database; Providing tissue biobank servicesaccess to a biobank of human biological and tissue samples; Providing medical information concerning quality of life in the fields of the treatment of cancerthe likelihood of success of the treatment of cancerthe physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; Providing medical information in the nature of medical data pertaining to cancer and its treatment; Providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; Providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
20/06/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/10/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/10/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/09/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/04/2018
PUBO
PUBLISHED FOR OPPOSITION
17/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/09/2017
GNRT
NON-FINAL ACTION E-MAILED
13/09/2017
CNRT
NON-FINAL ACTION WRITTEN
13/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/08/2017
ALIE
ASSIGNED TO LIE
14/08/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/07/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/05/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/05/2017
CNSI
SUSPENSION INQUIRY WRITTEN
10/05/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2016
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2016
CNSL
SUSPENSION LETTER WRITTEN
04/11/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/11/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/05/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/05/2016
CNSI
SUSPENSION INQUIRY WRITTEN
04/05/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/11/2015
GNSL
LETTER OF SUSPENSION E-MAILED
03/11/2015
CNSL
SUSPENSION LETTER WRITTEN
03/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/10/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/10/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/05/2015
GNRT
NON-FINAL ACTION E-MAILED
21/05/2015
CNRT
NON-FINAL ACTION WRITTEN
21/05/2015
DOCK
ASSIGNED TO EXAMINER
20/05/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2015
NWAP
NEW APPLICATION ENTERED
17/02/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXACTIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.